| GIGYF2 — GRB10 Interacting GYF Protein 2 | |
|---|---|
| Symbol | GIGYF2 |
| Full Name | GRB10 Interacting GYF Protein 2 |
| Chromosome | 5q33.2 |
| NCBI Gene | 26072 |
| Ensembl | ENSG00000146670 |
| OMIM | 612119 |
| UniProt | Q6UY1 |
| Protein Name | GIGYF2 (Grb10-Interacting GYF Protein 2) |
| Protein Length | 1,798 amino acids |
| Molecular Weight | ~199 kDa |
| Brain Expression | High: substantia nigra, cerebral cortex, hippocampus |
| Subcellular Localization | Cytoplasm, nucleus, synaptic vesicles |
| Associated Diseases | Parkinson's Disease, Essential Tremor, Neurodegeneration with Brain Iron Accumulation |
Gigyf2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GIGYF2 (GRB10 Interacting GYF Protein 2) is a gene located on chromosome 5q33.2 that encodes a large scaffold protein involved in insulin-like growth factor (IGF) signaling, receptor tyrosine kinase signaling, and cellular homeostasis[1]. The gene is catalogued as NCBI Gene ID 26072 and OMIM 612119.
GIGYF2 (also known as TIF2 or GRB10IP) is a 1,798 amino acid protein that serves as a critical adaptor protein linking growth factor receptors to downstream signaling pathways[2]. It interacts with GRB10 (Growth Factor Receptor Bound Protein 10), which itself is an important regulator of insulin and IGF-1 receptor signaling[3].
The discovery of GIGYF2 mutations as a cause of familial Parkinson's disease in 2009 established it as an important player in neurodegenerative disease pathogenesis[4]. Subsequent research has revealed its involvement in multiple pathways relevant to neuronal survival and function.
The GIGYF2 gene spans approximately 47 kb on chromosome 5q33.2 and contains 24 exons[1:1]. The gene produces multiple splice variants with potentially distinct cellular functions.
The GIGYF2 protein contains several functional domains[2:1]:
GIGYF2 plays a central role in insulin/IGF signaling pathways[2:2][3:1]:
GIGYF2 modulates several key cellular pathways:
Growth Factor (IGF-1, EGF) → RTK Activation → GRB10/GIGYF2 Complex
↓
PI3K/Akt Pathway
↓
Cell Survival/Proliferation
GIGYF2 participates in multiple cellular processes[5][6]:
GIGYF2 exhibits region-specific expression in the central nervous system[4:1][7]:
| Brain Region | Expression Level | Significance |
|---|---|---|
| Substantia Nigra | High | PD-affected region |
| Cerebral Cortex | High | Broad cortical functions |
| Hippocampus | High | Learning/memory |
| Cerebellum | Moderate | Motor coordination |
| Striatum | Moderate | Motor control |
| Thalamus | Moderate | Relay functions |
Within neurons, GIGYF2 localizes to:
GIGYF2 mutations were first linked to familial PD in 2009 through genome-wide association studies[4:2]:
Genetic Evidence:
Pathogenic Mechanisms:
GIGYF2 variants have also been associated with essential tremor[8]:
Recent studies link GIGYF2 to iron homeostasis[9]:
GIGYF2 mutations disrupt normal IGF signaling[3:2][5:1]:
GIGYF2 deficiency affects stress response[10]:
GIGYF2 plays a role in autophagy regulation[11]:
GIGYF2 expression may serve as:
The study of Gigyf2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Giovannone B, et al. (2009). GIGYF2 in insulin and IGF-1 signaling. J Biol Chem, 284(44), 30292-30304. ↩︎ ↩︎ ↩︎
Lim MA, et al. (2012). GRB10 and GIGYF2 in metabolic disease. Cell Signal, 24(1), 25-35. ↩︎ ↩︎ ↩︎
Lautier C, et al. (2008). Mutations in GIGYF2 in Parkinson disease. Nat Genet, 40(9), 1053-1055. ↩︎ ↩︎ ↩︎
Sun X, et al. (2011). GIGYF2 and IGF signaling in neurons. Mol Cell Neurosci, 47(3), 231-242. ↩︎ ↩︎
Zhang Z, et al. (2019). GIGYF2 in cellular stress response. Cell Death Discov, 5, 87. ↩︎
Guella I, et al. (2016). GIGYF2 expression in brain regions. Mol Neurobiol, 53(8), 5568-5579. ↩︎
Wu Y, et al. (2014). GIGYF2 variants in essential tremor. Parkinsonism Relat Disord, 20(9), 981-985. ↩︎
Yang W, et al. (2020). GIGYF2 and iron metabolism in neurodegeneration. Neurobiol Aging, 86, 123-134. ↩︎
Liu H, et al. (2017). GIGYF2 in neuronal stress response. J Neurosci Res, 95(6), 1457-1470. ↩︎
Chen X, et al. (2021). GIGYF2 regulates autophagy in PD models. Autophagy, 17(4), 1023-1038. ↩︎